The association of PD-L1 expression status and the PD-1/PD-L1 inhibitor-related toxicity profile in non-small cell lung cancer
Abstract Objective While PD-L1 expression serves as a predictive biomarker for programmed cell death 1 and its ligand (PD-1/PD-L1) inhibitor efficacy in patients with non-small cell lung cancer (NSCLC), its association with treatment-related adverse events (TRAEs) has yet to be fully elucidated. Thi...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2025-04-01
|
| Серія: | BMC Cancer |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12885-025-14218-5 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|